Application of probiotics in adjuvant treatment of infant allergic rhinitis: A randomized controlled study

Xueqiu Cao1,2, Ping Zhong1, Gang Li1

  • 1Hearing Center/Hearing and Speech Science Laboratory, Department of Otolaryngology Head and Neck Surgery, West China Hospital of Sichuan University, Chengdu.

Medicine
|May 3, 2020
PubMed

Insights

This study investigates if Bifidobacterium triplex probiotics can alleviate allergic rhinitis (AR) symptoms in children. The research aims to provide insights into probiotic efficacy for managing AR in young patients.

Area of Science:

  • Microbiology
  • Immunology
  • Pediatrics

Background:

  • Intestinal flora is increasingly recognized for its role in allergic diseases.
  • Previous research on probiotics for allergic rhinitis (AR) has primarily focused on animal models.

Purpose of the Study:

  • To investigate the efficacy of Bifidobacterium triplex probiotics in managing symptoms of allergic rhinitis in infants and young children.
  • To evaluate the impact of probiotics on the immune system in the context of AR.

Main Methods:

  • A randomized controlled trial design involving 60 infants and young children diagnosed with AR.
  • Participants were divided into two groups: one receiving probiotics and the other a placebo.
  • Outcomes measured include a comprehensive symptom drug score, rhinitis quality of life questionnaire, visual analog scale for allergy burden, and a second quality of life questionnaire.

Main Results:

  • The study design is detailed, outlining the methodology for assessing probiotic effects on AR symptoms and quality of life.
  • Specific quantitative results are pending the completion of the trial.

Conclusions:

  • The study is a double-center, randomized trial conducted at Minda Hospital of Hubei Minzu University and West China Hospital of Sichuan University.
  • The findings will contribute to understanding the therapeutic potential of probiotics for allergic rhinitis in pediatric populations.
Abstract